Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D (Details)

v3.10.0.1
Goodwill and In-process R&D (Details) - USD ($)
9 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Business Acquisition [Line Items]    
Goodwill $ 2,189,338 $ 2,189,338
Pelican Therapeutics, Inc. [Member]    
Business Acquisition [Line Items]    
Goodwill 2,189,338  
In-process R&D $ 5,900,000